Indicated for: reduction of antifolate toxicity; folate deficiency
Route of administration: injectable / infusion
Substance: calcium folate (vitamin)
ATC: V03AF03 (Various | All other therapeutic products | Detoxifying agents for antineoplastic treatment)
Calcii folinas is a medication used to reduce the toxicity and counteract the adverse effects of methotrexate in cancer treatment, as well as for the treatment of megaloblastic anemia caused by folic acid deficiency. It is an active form of folic acid that helps protect healthy cells during chemotherapy and supports normal DNA and RNA synthesis.
The medication is administered orally, intramuscularly, or intravenously, as directed by a doctor. The dosage and frequency of administration are adjusted based on the treatment purpose and the patient's response.
Common side effects include nausea, vomiting, diarrhea, and injection site reactions. In rare cases, severe allergic reactions or hematological disorders may occur.
Calcii folinas is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, it is important for patients to strictly adhere to the treatment regimen to maximize benefits and minimize associated risks.